GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptahem AB (XSAT:APTA) » Definitions » Price-to-Tangible-Book

Aptahem AB (XSAT:APTA) Price-to-Tangible-Book : (As of Dec. 14, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Aptahem AB Price-to-Tangible-Book?

As of today (2024-12-14), Aptahem AB's share price is kr1.185. Aptahem AB's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was kr-0.03. Hence, Aptahem AB's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Aptahem AB's Price-to-Tangible-Book or its related term are showing as below:

During the past 10 years, Aptahem AB's highest Price to Tangible Book Ratio was 39.65. The lowest was 0.33. And the median was 4.43.

XSAT:APTA's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.81
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Aptahem AB's share price is kr1.185. Aptahem AB's Book Value per Sharefor the quarter that ended in Sep. 2024 was kr10.25. Hence, Aptahem AB's P/B Ratio of today is 0.12.


Aptahem AB Price-to-Tangible-Book Historical Data

The historical data trend for Aptahem AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptahem AB Price-to-Tangible-Book Chart

Aptahem AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.99 3.78 1.72 5.68 -

Aptahem AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.65 - 9.06 10.27 -

Competitive Comparison of Aptahem AB's Price-to-Tangible-Book

For the Biotechnology subindustry, Aptahem AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptahem AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptahem AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Aptahem AB's Price-to-Tangible-Book falls into.



Aptahem AB Price-to-Tangible-Book Calculation

Aptahem AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2024 )
=1.185/-0.032
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Aptahem AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Aptahem AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptahem AB Business Description

Traded in Other Exchanges
N/A
Address
Norra Vallgatan 58, Malmo, SWE, 211 22
Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.

Aptahem AB Headlines

No Headlines